Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Netherlands
Cannabis sativa blad en bloem extract, chemotype cannabidiol

CBG-MEB 2012

Cannabis sativa blad en bloem extract, chemotype cannabidiol, Cannabis sativa blad en bloem extract, chemotype tetrahydrocannabiol

Sativex, spray voor oromucosaal gebruik

Spray voor oromucosaal gebruikNetherlandsAuthorisedAuthorised 18 Jul 2012

Product informationAsk Osler about it

On this page

Documents
Sources and licences

Documents

The official texts, at the regulator.

Summary of product characteristicsCBG-MEB
Package leafletCBG-MEB
Register entryCBG-MEB

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removal

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Corrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Cannabis sativa blad en bloem extract, chemotype cannabidiol, Cannabis sativa blad en bloem extract, chemotype tetrahydrocannabiol
Dosage form: Spray voor oromucosaal gebruik
Route: Oromucosaal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 18 Jul 2012
Registration: 111277
Marketing authorisation holder: CNX Therapeutics Ireland Limited
ATC code: N02BG10
Group: Nervous system
Procedure: National (RVG)
Supply: Uitsluitend recept